The broad-spectrum antimicrobial activity of PI3 and SLPI proteins have led to investigation into their potential as treatments for infectious diseases, and could therefore be explored as adjunct antimicrobials for keratitis (Williams et al., 2006). This evidence concerns the gene PI3 and infectious disease.